These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2446479)

  • 1. Inhibition of C5a-induced basophil degranulation by disodium cromoglycate.
    Golden HW; Iacuzio DA; Otterness IG
    Agents Actions; 1987 Aug; 21(3-4):371-4. PubMed ID: 2446479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of disodium cromoglycate on cutaneous basophil anaphylaxis.
    Golden HW; Crean GL; Iacuzio DA; Otterness IG
    J Immunol; 1986 Sep; 137(5):1495-503. PubMed ID: 2427571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
    Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
    Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiallergic activity of tiaramide (RHC 2592-A).
    Khandwala A; Coutts S; Weinryb I
    Int Arch Allergy Appl Immunol; 1982; 69(2):159-68. PubMed ID: 6179887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular guanosine 3',5'-cyclic monophosphate and disodium cromoglycate share a similar spectrum of activity in the inhibition of histamine release from isolated mast cells and basophils.
    Mackay GA; Pearce FL
    Int Arch Allergy Immunol; 1996 Mar; 109(3):258-65. PubMed ID: 8620095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions.
    Shin HY; Kim JS; An NH; Park RK; Kim HM
    Life Sci; 2004 Apr; 74(23):2877-87. PubMed ID: 15050425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rejection of ticks from guinea pigs by anti-hapten-antibody-mediated degranulation of basophils at cutaneous basophil hypersensitivity sites: role of mediators other than histamine.
    Brown SJ; Askenase PW
    J Immunol; 1985 Feb; 134(2):1160-5. PubMed ID: 2578152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
    Khandwala A; Dally-Meade V; Jariwala N; Huang F
    Int Arch Allergy Appl Immunol; 1984; 73(1):65-70. PubMed ID: 6198288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of ascorbic acid and disodium cromoglycate in some models of experimental anaphylaxis.
    González RG; García M; Pérez Saad H; de la Vega AR
    Allergol Immunopathol (Madr); 1979; 7(3):211-6. PubMed ID: 89807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-induced histamine release from mast cells and basophils after hydrocortisone and disodium cromoglycate treatment.
    Hofman J; Chyrek-Borowska S
    Agents Actions; 1981 Apr; 11(1-2):107-9. PubMed ID: 6166161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 3-dependent mediator release in basophils triggered by C5a.
    Kurimoto Y; de Weck AL; Dahinden CA
    J Exp Med; 1989 Aug; 170(2):467-79. PubMed ID: 2474054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiallergic activity of nylidrin hydrochloride (RHC 3432-A). I. Effect on release of histamine in vitro from rat peritoneal mast cells, guinea pig lung slices and human basophils.
    Khandwala A; Coutts SM; Weinryb I
    Int Arch Allergy Appl Immunol; 1983; 70(4):295-302. PubMed ID: 6186608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
    Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of disodium cromoglycate and other inhibitors on in vitro anaphylactic histamine release from guinea pig basophil leucocytes.
    Greaves MW
    Int Arch Allergy Appl Immunol; 1969; 36(5):497-505. PubMed ID: 4187085
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiallergic activity profile in vitro of RHC 2963 and related compounds.
    Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Youssefyeh RD
    Int J Immunopharmacol; 1983; 5(6):491-502. PubMed ID: 6198298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A binding site on mast cells and basophils for the anti-allergic drug cromolyn.
    Mazurek N; Berger G; Pecht I
    Nature; 1980 Aug; 286(5774):722-3. PubMed ID: 6157990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protective action of disodium cromoglycate against the contraction of guinea-pig ileum induced by various pharmacological stimulants.
    Kazimierczak W; Gonzalez Alvarez R; Maśliński C
    Agents Actions; 1980 Apr; 10(1 Pt 2):8-14. PubMed ID: 6155773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RHC 3024: antiallergic activity in vitro and comparison with disodium cromoglycate and other antiallergic agents.
    Khandwala A; Coutts SM; Dally-Meade V; Jariwala N; Huang FC
    Int Arch Allergy Appl Immunol; 1983; 70(4):311-20. PubMed ID: 6186610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of disodium cromoglycate on in vitro mast cell degranulation in human jejunal mucosa.
    Selbekk BH
    Allergy; 1979 Oct; 34(5):283-8. PubMed ID: 121046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.